Ichor Life Sciences Invests $1.5 Million In MitoChem Therapeutics for Ocular Aging Disease Research - News - Charleston Digital Corridor

August 15, 2022

Ichor Life Sciences Invests $1.5 Million In MitoChem Therapeutics for Ocular Aging Disease Research

MitoChem Therapeutics

Ichor Life Sciences, a preclinical contract research organization, today announced a $1.5 million investment in MitoChem Therapeutics. Read more: